Gardasil Approved to Prevent Genital Warts in Males

powered by healthline

Average Ratings

Caused by human papillomavirus

MONDAY, Oct. 19 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved use of the cervical cancer vaccine Gardasil to prevent genital warts caused by human papillomavirus (HPV) types 6 and 11 in boys and men, ages 9 through 26.

Each year, about two of every 1,000 men in the United States are newly diagnosed with genital warts, the FDA said.

Gardasil currently is approved for use in girls and women ages 9 through 26 to prevent cervical, vulvar and vaginal cancer caused by HPV types 16 and 18; precancerous lesions caused by types 6, 11, 16, and 18; and genital warts caused by types 6 and 11, the agency said.

HPV is the most common sexually transmitted infection in the United States and most genital warts are caused by HPV infection.

More information

The FDA has more about this approval.



Copyright © 2009 ScoutNews, LLC. All rights reserved.
Article from
Top of page
General Drug Tools
General Drug Tools view all tools
Tools for
Healthy Living
Tools for Healthy Living view all tools
Search Tools
Search Tools view all tools
Insurance Plan Tools
Insurance Plan Tools view all tools

What is a reference number?

When you register on this site, you are assigned a reference number. This number contains your profile information and helps UnitedHealthcare identify you when you come back to the site.

If you searched for a plan on this site in a previous session, you might already have a reference number. This number will contain any information you saved about plans and prescription drugs. To use that reference number, click on the "Change or view saved information" link below.

You can retrieve information from previous visits to this site, such as saved drug lists and Plan Selector information.